QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This Phase III clinical trial aims to assess the efficacy and safety of QLC7401 Treatment in adults with Heterozygous Familial Hypercholesterolemia on a stable lipid-lowering therapy. Participants will be randomly assigned to receive subcutaneous injections of either QLC7401 or a placebo according to the study schedule.
Epistemonikos ID: b83ac0dc29995a270f0977d021ffbf66ae83fc7c
First added on: Mar 05, 2026